Assembly Biosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio3.527.5317.832.53
P/B Ratio3.011.310.770.660.83
Price/Tangible Book3.011.310.770.661.00
Price/FCF2.40
Price/OCF2.37
Enterprise Value Ratios
EV/Revenue0.241.21
EV/FCF0.39
Profitability & Returns
Return on Equity (ROE)-1.08%-0.99%-0.74%-0.63%-0.24%
Return on Assets (ROA)-0.22%-0.34%-0.40%-0.24%-0.12%
Return on Capital Employed (ROCE)-0.64%-0.66%-1.09%-0.53%-0.23%
Leverage & Solvency Ratios
Debt/Equity0.090.060.040.040.04
Debt/FCF0.10
Liquidity Ratios
Current Ratio2.423.415.959.599.19
Quick Ratio2.353.335.709.148.91
Efficiency Ratios
Asset Turnover0.220.060.030.25
Yield & Distribution Ratios
Earnings Yield-0.40%-1.13%-1.47%-1.16%-0.31%
FCF Yield-0.51%0.42%-1.33%-0.87%-0.32%
Buyback Yield-0.31%-0.13%-0.12%-0.22%-0.35%